The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005

被引：47

作者：

M Aricó

A Baruchel

Y Bertrand

A Biondi

V Conter

T Eden

H Gadner

P Gaynon

K Horibe

S P Hunger

G Janka-Schaub

G Masera

J Nachman

R Pieters

M Schrappe

K Schmiegelow

M G Valsecchi

C-H Pui

机构：

[1] Associazione Italiana di Ematologia ed Oncologia Pediatrica,Medical Research Council/National Cancer Research Institute

[2] French Acute Lymphoblastic Leukemia Study Group,undefined

[3] European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group,undefined

[4] United Kingdom Acute Lymphoblastic Leukemia Working Party,undefined

[5] Berlin–Frankfurt–Münster Group,undefined

[6] Children's Oncology Group,undefined

[7] Japan Association of Childhood Leukemia Study,undefined

[8] Cooperative Acute Lymphoblastic Leukemia Study Group,undefined

[9] Dutch Childhood Oncology Group,undefined

[10] Nordic Society of Pediatric Haematology and Oncology,undefined

[11] St Jude Children's Research Hospital,undefined

来源：

Leukemia | 2005年 / 19卷 / 7期

关键词：

childhood acute lymphoblastic leukemia; minimal residual disease; glucocorticoids; methotrexate; anthracycline; intrathecal therapy;

D O I：

10.1038/sj.leu.2403783

中图分类号：

学科分类号：

摘要：

Between 1995 and 2004, six International Childhood Acute Lymphoblastic Leukemia (ALL) Workshop have been held, and the completion of several collaborative projects has established the clinical relevance and treatment options for several specific genetic subtypes of ALL. This meeting report summarizes the data presented in the seventh meeting and the discussion.

引用

页码：1145 / 1152

页数：7

共 208 条

[1]

Pui CH(1995)Meeting report: International Childhood ALL Workshop: Memphis, TN, 3–4 December 1997 Leukemia 12 1313-1318

[2]

Evans WE(2001)International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November–1 December 2000 Leukemia 15 707-715

[3]

Gilbert JR(2003)‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April–1 May 2002 Leukemia 17 798-803

[4]

Pui CH(2004)Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop Leukemia 18 1043-1053

[5]

Sallan S(2004)Acute lymphoblastic leukemia N Engl J Med 350 1535-1548

[6]

Relling MV(2002)Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group Blood 99 825-833

[7]

Masera G(2003)Determination of minimal residual disease in leukaemia patients Br J Haematol 121 823-838

[8]

Evans WE(2001)Minimal residual disease in leukaemia patients Lancet Oncol 2 409-417

[9]

Gadner H(2005)Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology Haematologica 90 382-390

[10]

Haas OH(2000)New definition of remission in childhood acute lymphoblastic leukemia Leukemia 14 783-785

← 1 2 3 4 5 6 7 8 9 10 →